propranolol has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 6 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In Parkinson's disease (PD), the long term use of L-DOPA results in major adverse effects including dyskinesia or abnormal involuntary movements." | 1.36 | The selective alpha1 adrenoceptor antagonist HEAT reduces L-DOPA-induced dyskinesia in a rat model of Parkinson's disease. ( Buck, K; Ferger, B, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Sharma, VD | 1 |
| Gupta, HV | 1 |
| Espay, AJ | 1 |
| Dietlein, M | 1 |
| Dietlein, F | 1 |
| Drzezga, A | 1 |
| Bhide, N | 1 |
| Lindenbach, D | 1 |
| Barnum, CJ | 1 |
| George, JA | 1 |
| Surrena, MA | 1 |
| Bishop, C | 1 |
| Buck, K | 1 |
| Ferger, B | 1 |
| Davies, JS | 1 |
| Morrish, PK | 1 |
| Scanlon, MF | 1 |
6 other studies available for propranolol and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
Copulatory Dyskinesia: Pathognomonic Manifestation of Tardive Dyskinesia.
Topics: Adrenergic beta-Antagonists; Aged; Aripiprazole; Clonazepam; Deprescriptions; Depressive Disorder; D | 2020 |
Topics: Adrenergic beta-Antagonists; Animals; Drug Utilization; Humans; Parkinsonian Disorders; Propranolol | 2018 |
Effects of the beta-adrenergic receptor antagonist Propranolol on dyskinesia and L-DOPA-induced striatal DA efflux in the hemi-parkinsonian rat.
Topics: Adrenergic beta-Antagonists; Animals; Antiparkinson Agents; Chromatography, High Pressure Liquid; Co | 2015 |
The selective alpha1 adrenoceptor antagonist HEAT reduces L-DOPA-induced dyskinesia in a rat model of Parkinson's disease.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; | 2010 |
Controlling essential tremor.
Topics: Diagnosis, Differential; Essential Tremor; Health Status; Humans; Middle Aged; Neurologic Examinatio | 2012 |
Graves' disease presenting as hemiparkinsonism.
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Autoantibodies; Carbimazole; Diagnosis, Diff | 2001 |